natgillin/translations-raw huggingface dataset:
Den observerede øgede risiko for frakturer hos kvinder i behandling med pioglitazon i dette forsøg er derfor 0,5 frakturer pr. 100 patientårs brug. 
The observed excess risk of fractures for women on pioglitazone in this study is therefore 0.5 fractures per 100 patient years of use.
1 Moderat til svær trombocytopeni, leukopeni, erytrocytopeni, granulocytopeni, agranulocytose, hæmolytisk anæmi og pancytopeni kan forekomme. 
1 Moderate to severe thrombocytopenia, leucopenia, erythrocytopenia, granulocytopenia, agranulocytosis, haemolytic anaemia and pancyto-penia may occur.
Den observerede overhyppighed af frakturer for pioglitazonbehandlede kvinder i dette datasæt er derfor 0,8 frakturer pr. 100 patientår. 
The observed excess risk of fractures for women in this dataset on pioglitazone is therefore 0.8 fractures per 100 patient years of use.
Hypoglykæmi (lavt blodsukker) er rapporteret med hyppigheden "ikke almindelig" (kan forekomme hos op til 1 ud af 100 behandlede) hos patienter, som tager Tandemact. 
Hypoglycaemia (low blood sugar) has been reported uncommonly (may affect up to 1 in 100 people) in patients taking Tandemact.
Thiazolidinedionerne virker primært ved at reducere insulinresistens og sulfonylurinstofferne virker primært ved at stimulere insulinfrigivelse fra bugspytkirtlens beta-celler. 
Thiazolidinediones act primarily by reducing insulin resistance and sulphonylureas primarily by inducing insulin release from pancreatic beta cells.
Tag ikke Tandemact: - hvis De er allergisk over for pioglitazon, glimepirid, andre sulfonylurinstoffer eller sulfonamider eller over for et af de øvrige indholdsstoffer i dette lægemiddel (angivet i punkt 6) - hvis De lider af eller tidligere har lidt af hjertesvigt - hvis De har en leversygdom - hvis De har diabetisk ketoacidose (en komplikation ved diabetes med hurtigt vægttab, kvalme eller opkastning) - hvis De har alvorlige nyreproblemer - hvis De har eller nogensinde har haft blærekræft - hvis De har blod i urinen, og Deres læge ikke har undersøgt årsagen - hvis De har insulinkrævende diabetes (type 1) 
Do not take Tandemact: - if you are allergic to pioglitazone, glimepiride, other sulphonylureas or sulphonamides, or any of the other ingredients of this medicine (listed in section 6) - if you have heart failure or have had heart failure in the past - if you have liver disease - if you have diabetic ketoacidosis (a complication of diabetes with rapid weight loss, nausea or vomiting) - if you have severe problems with your kidneys - if you have or have ever had bladder cancer - if you have blood in your urine that your doctor has not checked - if you have insulin dependent diabetes (type 1) - if you are in a diabetic coma - if you are pregnant - if you are breast-feeding
Af hensyn til miljøet må De ikke smide medicinrester i afløbet, toilettet eller skraldespanden. 
Do not throw away any medicines via waste water or household waste.
Der sås proportionale stigninger i plasmakoncentrationen for doser fra 2-60 mg. Steady-state opnås efter 4-7 dages dosering. 
Proportional increases of the plasma concentration were observed for doses from 2-60 mg.
komparatorkontrollerede, dobbeltblinde kliniske forsøg med over 8.100 patienter i den pioglitazon-behandlede gruppe og 7.400 patienter i den komparatorbehandlede gruppe, der blev behandlet i op til 3,5 år. 
7 A pooled analysis was conducted of adverse event reports of bone fractures from randomised, comparator controlled, double blind clinical trials in over 8,100 patients in the pioglitazone-treated groups and 7,400 in the comparator-treated groups of up to 3.5 years duration.
coumarin-derivater som f.eks. warfarin (til behandling af hjerte- eller blodproblemer) - allopurinol, probenecid, sulfinpyrazon (til behandling af gigt) - cyclophosphamid, ifosfamid, trofosfamid (til behandling af kræft) - fenfluramin (til vægtreduktion) - tritoqualin (til behandling af allergier) 
coumarin derivatives such as warfarin (to treat heart or blood problems) - allopurinol, probenecid, sulfinpyrazone (to treat gout) - cyclophosphamide, ifosfamide, trofosfamide (to treat cancer) - fenfluramine (to reduce weight) - tritoqualine (to treat allergies)
Nyrer og urinveje glukosuri ikke almindelig proteinuri ikke almindelig 
Renal and urinary disorders glycosuria uncommon proteinuria uncommon
10 I kliniske forsøg med pioglitazon var hyppigheden af forhøjelser i ALT større end tre gange den øvre grænse for normal lig med placebo men mindre end det observerede i sammenligningsgrupperne med metformin og sulfonylurinstof. 
In clinical trials with pioglitazone the incidence of elevations of ALT greater than three times the upper limit of normal was equal to placebo but less than that seen in metformin or sulphonylurea comparator groups.
- hvis De har en særlig type af diabetisk øjensygdom kaldet makulært ødem (hævelse i det bagerste af øjet). 
- if you have a special type of diabetic eye disease called macular oedema (swelling of the back of the eye), talk to your doctor if you notice any change to your vision.
Der sås ikke hyperplasi af urinblæren hos hunde eller aber, der var blevet med pioglitazon behandlet i op til 12 måneder. 
There was no tumourigenic response in mice of either sex. Hyperplasia of the urinary bladder was not seen in dogs or monkeys treated with pioglitazone for up to 12 months.
Når De har taget Tandemact i 3-6 måneder, vil Deres læge undersøge, om medicinen virker. 
Your doctor will check whether Tandemact is working 3 to 6 months after you start taking it.
Bed Deres læge eller apoteket om yderligere information, hvis De ikke er sikker på, at De kan genkende disse symptomer. 
Ask your doctor or pharmacist for more information if you are not sure how to recognise this.
8 I kontrollerede kliniske forsøg blev der rapporteret ødemer hos 6-9 % af de patienter, der blev behandlet med pioglitazon i mere end ét år. 
8 Oedema was reported in 6-9% of patients treated with pioglitazone over one year in controlled clinical trials.
Tandemact indeholder: - Aktive stoffer: pioglitazon og glimepirid. 
What Tandemact contains - The active substances are pioglitazone and glimepiride.
Tandemact påvirker i mindre grad evnen til at føre motorkøretøj og betjene maskiner. 
4.7 Effects on ability to drive and use machines Tandemact has minor influence on the ability to drive and use machines.
KVALITATIV OG KVANTITATIV SAMMENSÆTNING Tandemact 30 mg/2 mg tabletter 
QUALITATIVE AND QUANTITATIVE COMPOSITION Tandemact 30 mg/2 mg tablets
Følgende lægemidler kan nedsætte den blodsukkersænkende virkning af Tandemact. 
The following medicines may decrease the blood sugar lowering effect of Tandemact.
To metabolitter, hydroxyderivatet og carboxyderivatet, som formentlig er fremkommet under levermetabolismen (hovedenzymet er CYP2C9), blev identificeret både i urin og fæces. 
Two metabolites - most probably resulting from hepatic metabolism (major enzyme is CYP2C9) - were identified both in urine and faeces: the hydroxy derivative and the carboxy derivative.
Knogler, led, muskler og bindevæv knoglefraktur7 
Musculoskeletal and connective tissue disorders bone fracture7
Leverenzymernes middelniveauer faldt ved behandling med pioglitazon. 
Mean levels of liver enzymes decreased with treatment with pioglitazone.
Der er i behandlingen med glimepirid observeret sjældne hæmatologiske ændringer (se pkt. 
Rare changes in haematology have been observed with glimepiride treatment (see section 4.8).
Ikke almindelige: (kan påvirke op til 1 ud af 100 behandlede) - hovedpine - bihulebetændelse (sinuitis) - svimmelhed - abnormt syn (synsforstyrrelser) - svedudbrud - træthed - problemer med at falde i søvn (søvnløshed) - nedsat blodsukker - sukker i urinen - proteiner i urinen - øget appetit - forhøjelse af et enzym kaldet laktisk dehydrogenase (LDH) 
- headache - inflammation of the sinuses (sinusitis) - vertigo - abnormal vision - sweating - tiredness - difficulty sleeping (insomnia) - decreased blood sugar - sugar in urine - proteins in urine - increased appetite - increase of an enzyme called lactic dehydrogenase (LDH)
I PROactive-forsøget, som forløb over 3,5 år, fik 44/870 (5,1 %; 1,0 frakturer pr. 100 patientår) af de pioglitazon-behandlede kvindelige patienter frakturer. 
In the 3.5 year PROactive study, 44/870 (5.1%; 1.0 fractures per 100 patient years) of pioglitazone-treated female patients experienced fractures compared to 23/905 (2.5%; 0.5 fractures per 100 patient years) of female patients treated with comparator.
Disse er relateret til ændringer i blodsukkeret på grund af forbigående ændringer i linsens turgiditet og refraktionsindeks, som det også ses ved andre hypoglykæmiske lægemidler. 
4 Visual disturbance has been reported mainly early in treatment and is related to changes in blood glucose due to temporary alteration in the turgidity and refractive index of the lens as seen with other hypoglycaemic medicinal products.
Der har været post marketing-tilfælde af hjerteinsufficiens, hvor pioglitazon har været anvendt i kombination med insulin eller hos patienter med hjerteinsufficiens i anamnesen. 
There have been post-marketing cases of cardiac failure reported when pioglitazone was used in combination with insulin or in patients with a history of cardiac failure.
Desuden har glimepirid høj proteinbinding (> 99 %) og lav clearance (cirka 48 ml/min). 
Glimepiride has a very low distribution volume (approximately 8.8 litres) which is roughly equal to the albumin distribution space, high protein binding (> 99%), and a low clearance (approximately 48 mL/min).
Hud og subkutane væv svedudbrud ikke almindelig lysoverfølsomhed meget sjælden meget sjælden nældefeber2 
Skin and subcutaneous tissue disorders sweating uncommon hypersensitivity to light very rare very rare urticaria2
6 Der kan forekomme forhøjede leverenzymer. 
6 Elevation of liver enzymes may occur.
Dette kan medføre en risiko for hypoglykæmi (lavt blodsukker): - gemfibrozil og fibrater (for at sænke højt kolesteroltal) - insulin, metformin eller andre lægemidler til behandling af diabetes mellitus - phenylbutazon, azopropazon, oxyphenbutazon, aspirin-lignende lægemidler (til behandling af smerter og inflammation) - langtidsvirkende sulfonamider, tetracykliner, chloramphenicol, fluconazol, miconazol, 
This can lead to a risk of hypoglycaemia (low blood sugar): - gemfibrozil and fibrates (to lower high cholesterol level) - insulin, metformin or other medicines to treat diabetes mellitus - phenylbutazone, azapropazone, oxyphenbutazone, aspirin-like medicines (to treat pain and inflammation) - long acting sulphonamides, tetracyclines, chloramphenicol, fluconazole, miconazole,
Advarsler og forsigtighedsregler Kontakt lægen eller apotekspersonalet, før De tager Tandemact (se også punkt 4), 
Talk to your doctor or pharmacist before taking Tandemact (see also section 4) - if you have a problem with your heart.
Symptomerne kan omfatte koldsved, træthed, hovedpine, hurtige hjerteslag, stik af sult, irritabilitet, nervøsitet eller kvalme. 
The symptoms may include cold sweat, tiredness, headache, rapid heartbeat, hunger pangs, irritability, nervousness or nausea.
Følgende lægemidler kan øge den blodsukkersænkende virkning af Tandemact. 
The following medicines can increase the blood sugar lowering effect of Tandemact.
Glimepirid passerer kun blod-hjernebarrieren i ringe grad. 
Passage of the blood brain barrier is low.
Der er udført kliniske forsøg med samtidig administration af pioglitazon og glimepirid (se pkt. 
Clinical trials have been conducted with co-administered pioglitazone and glimepiride (see section 5.1).
Lokal hævelse (ødem) er også observeret med hyppigheden "almindelig" (kan forekomme hos op til 1 ud af 10 behandlede hos patienter, som får Tandemact i kombination med insulin. 
Localised swelling (oedema) has also been experienced commonly (may affect up to 1 in 10 people) in patients taking Tandemact in combination with insulin.
I en poolet analyse af bivirkningsrapporter om knoglefrakturer fra randomiserede, kontrollerede, dobbeltblindede kliniske forsøg blev der set en forøget incidens af frakturer hos kvinder (se pkt. 
An increased incidence in bone fractures in women was seen in a pooled analysis of adverse reactions reports of bone fracture from randomised, controlled, double blind clinical trials (see section 4.8).
Overfølsomhedsreaktioner i huden kan optræde som kløe, udslæt og nældefeber. 
Hypersensitivity reactions of the skin may occur as itching, rash, and urticaria.
Infektioner og parasitære sygdomme øvre luftvejsinfektion almindelig almindelig bihulebetændelse ikke almindelig ikke almindelig 
Infections and infestations upper respiratory tract infection common common sinusitis uncommon uncommon
østrogener og progestagener, saluretika, tiaziddiuretika, thyroidstimulerende midler, glukokortikoider, phenotiazinderivater, chlorpromazin, adrenalin og sympatomimetika, nicotinsyre (høje doser) og nicotinsyrederivater afføringsmidler (langtidsbrug), 
oestrogens and progestagens, saluretics, thiazide diuretics, thyroid stimulating agents, glucocorticoids, phenothiazine derivatives, chlorpromazine, adrenaline and sympathicomimetics, nicotinic acid (high doses) and nicotinic acid derivatives, laxatives (long-term use), phenytoin, diazoxide, glucagon, barbiturates and rifampicin.
Symptomerne kan omfatte koldsved, træthed, hovedpine, hurtige hjerteslag, stik af sult, irritabilitet, nervøsitet, kvalme, koma eller krampeanfald. 
The symptoms may include cold sweat, tiredness, headache, rapid heartbeat, hunger pangs, irritability, nervousness, nausea, coma or convulsion.
Blærekræft forekommer med hyppigheden "ikke almindelig" (kan forekomme hos op til 1 ud af 100 behandlede) hos patienter, der tager Tandemact. 
Bladder cancer has been experienced uncommonly (may affect up to 1 in 100 people) in patients taking Tandemact.
Sådan skal De tage Tandemact 
How to take Tandemact
Hos patienter med lav kreatininclearance sås en tendens til stigende clearance af glimepirid og faldende gennemsnitlige serumkoncentrationer. 
In patients with low creatinine clearance, there was a tendency for glimepiride clearance to increase and for average serum concentrations to decrease, most probably resulting from a more rapid elimination because of lower protein binding.
ikke kendt ikke kendt kløe2 
not known not known rash2
Der var mindre, men ikke klinisk signifikante stigninger i LDL-kolesterolniveauer. 
HDL-cholesterol levels were observed as compared to placebo, with small, but not clinically significant increases in LDL-cholesterol levels.
In vitro-undersøgelser har ikke vist hæmning af nogen CYP-undertyper. 
In vitro studies have shown no inhibition of any subtype of cytochrome P450.
Tandemact 45 mg/4 mg tabletter 
Tandemact 45 mg/4 mg tablets
Tandemact er kontraindiceret under amning (se pkt. 
Tandemact is contra-indicated during breast-feeding (see section 4.3).
6.1, eller over for andre sulfonylurinstoffer eller sulfonamider - svigtende hjertefunktion eller en anamnese med hjertesvigt (NYHA grad I til IV) - aktuel blærecancer eller blærecancer i anamnesen - ikke udredt makroskopisk hæmaturi - nedsat leverfunktion - type 1-diabetes mellitus - diabetisk koma - diabetisk ketoacidose - svære nyrelidelser (kreatininclearance < 30 ml/min) - graviditet - amning (se pkt. 
- Hypersensitivity to the active substances or to any of the excipients listed in section 6.1, or other sulphonylureas or sulphonamides - Cardiac failure or history of cardiac failure (NYHA stages I to IV) - Current bladder cancer or a history of bladder cancer - Uninvestigated macroscopic haematuria - Hepatic impairment - Type 1 diabetes mellitus - Diabetic coma - Diabetic ketoacidosis - Severe renal function disorders (creatinine clearance < 30 ml/min) - Pregnancy - Breast-feeding (see section 4.6)
quinoloner, clarithromycin (til behandling af bakterie- og svampeinfektioner) - anabolske steroider (til muskelopbygning) eller erstatningsbehandling med mandlige kønshormoner - fluoxetin, MAO-hæmmere (til behandling af depression) - angiotensinkonverterende enzym (ACE)-hæmmere, sympatolytika, disopyramid, pentoxifyllin, 
- anabolic steroids (supporting muscle build up) or male sex hormone replacement therapy - fluoxetine, MAO-inhibitors (to treat depression) - angiotensin-converting enzyme (ACE) inhibitors, sympatholytics, disopyramide, pentoxifylline,
Tandemact bør ikke anvendes til kvinder i den fertile alder, som ikke anvender sikker kontraception. 
Women of childbearing potential / Contraception in males and females Tandemact is not recommended in women of childbearing potential not using contraception.
almindelig træthed ikke almindelig 
common fatigue uncommon
Tandemact 30 mg/2 mg tabletter Tandemact 30 mg/4 mg tabletter Tandemact 45 mg/4 mg tabletter pioglitazon/glimepirid 
Tandemact 30 mg/2 mg tablets Tandemact 30 mg/4 mg tablets Tandemact 45 mg/4 mg tablets pioglitazone/glimepiride
Indehaver af markedsføringstilladelsen Takeda Pharma A/S 
Marketing authorisation holder Takeda Pharma A/S Dybendal Alle 10
Der er rapporter om, at samtidig administration af pioglitazon og gemfibrozil (en hæmmer af CYP2C8) har resulteret i en 3-dobbelt stigning i AUC for pioglitazon. 
Co-administration of pioglitazone with gemfibrozil (an inhibitor of cytochrome P450 2C8) is reported to result in a 3-fold increase in AUC of pioglitazone.
INFORMATION I BRAILLESKRIFT Tandemact 45 mg/4 mg 
INFORMATION IN BRAILLE Tandemact 45 mg/4 mg
- Tandemact 45 mg/4 mg tabletterne er hvide til off-white, runde og flade og præget ‘4833 G' på den ene side og ‘45/4' på den anden side. 
- Tandemact 45 mg/4 mg tablets are white to off-white, round, flat and debossed ‘4833 G' on one face and ‘45/4' on the other.
Hvis De oplever denne bivirkning, skal De hurtigst muligt kontakte Deres læge. 
If you experience this side effect, talk to your doctor as soon as possible.
Meget sjældne (Kan forekomme hos op til 1 ud af 10.000 behandlede) - leversygdom - allergiske reaktioner herunder allergisk shock - kvalme (nausea), opkastning og diarre - mavesmerter - trykken i maven - oppustethed i maven - øget følsomhed for lys - nedsat indhold af salt (natrium) i blodet 
- allergic reactions including allergic shock - feeling sick (nausea), vomiting and diarrhoea - stomach ache - abdominal pressure - feeling of fullness in the stomach - sensitivity to light - decrease in salt (sodium) concentrations in the blood
INFORMATION I BRAILLESKRIFT Tandemact 30 mg/2 mg 
INFORMATION IN BRAILLE Tandemact 30 mg/2 mg
Tandemact 30 mg/4 mg tabletter 
Tandemact 30 mg/4 mg tablets
Hvis Deres vægt stiger, skal De kontakte Deres læge. 
Your weight should be checked at regular intervals; if your weight increases, inform your doctor.
Den forsinkede fostervækst skyldtes, at pioglitazon mindskede den maternale hyperinsulinæmi og en øget insulinresistens, som optræder under drægtighed. 
This was attributable to the action of pioglitazone in diminishing the maternal hyperinsulinaemia and increased insulin resistance that occurs during pregnancy thereby reducing the availability of metabolic substrates for foetal growth.
Nedsat leverfunktion Tandemact bør ikke anvendes til patienter med nedsat leverfunktion (se pkt. 
Hepatic impairment Tandemact should not be used in patients with hepatic impairment (see section 4.3 and 4.4).
I en bred vifte af genotoksicitetsundersøgelser in vivo og in vitro var pioglitazon uden genotoksisk potentiale. 
Pioglitazone was devoid of genotoxic potential in a comprehensive battery of in vivo and in vitro genotoxicity assays.
INFORMATION I BRAILLESKRIFT Tandemact 30 mg/4 mg 
INFORMATION IN BRAILLE Tandemact 30 mg/4 mg
Der er set henholdsvis en øgning eller en nedsættelse af plasmakoncentrationen af pioglitazon ved samtidig administration af pioglitazon og gemfibrozil (en hæmmer af CYP2C8) eller rifampicin (en inducer af CYP2C8) (se pkt. 
Concomitant administration of pioglitazone with gemfibrozil (an inhibitor of cytochrome P450 2C8) or with rifampicin (an inducer of cytochrome P450 2C8) is reported to increase or decrease, respectively, the plasma concentration of pioglitazone (see section 4.5).
Brug af anden medicin sammen med Tandemact Fortæl altid lægen eller apotekspersonalet, hvis De tager anden medicin eller har gjort det for nylig. 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Hver Tandemact 45 mg/4 mg tablet indeholder 45 mg pioglitazon (som hydrochlorid) og 4 mg glimepirid. 
Each Tandemact 45 mg/4 mg tablet contains 45 mg pioglitazone (as hydrochloride) and 4 mg glimepiride.
- H2-antagonister (til behandling af mavesår) - betablokkere, clonidin, guanethidin og reserpin (til behandling af højt blodtryk eller hjertesvigt) 
The following medicines can increase or decrease the blood sugar lowering effect of Tandemact: - H2 antagonists (to treat stomach ulcers) - beta-blockers, clonidine, guanethidine and reserpine (to treat high blood pressure or heart failure).
Dette kan medføre en risiko for hyperglykæmi (højt blodsukker): - østrogener, progestogener (kvindelige kønshormoner) - thiaziddiuretika og saluretika, også kaldet vanddrivende tabletter (til behandling af højt blodtryk) - levothyroxin (til stimulering af skjoldbruskkirtlen) - glukokortikoider (til behandling af allergier og inflammation) - chlorpromazin og andre phenothiazin-derivater (til behandling af svære psykiske lidelser) - adrenalin og sympatomimetika (til øgning af hjerterytmen, behandling af astma eller tilstoppet næse, hoste og forkølelse eller i akutte livstruende nødsituationer) - nikotinsyre (til behandling af højt kolesteroltal) - langvarig brug af laksativer (til behandling af forstoppelse) - phenytoin (til behandling af krampeanfald) - barbiturater (til behandling af nervøsitet og søvnproblemer) - azetazolamid (til behandling af øget tryk i øjet, også kaldet glaukom) - diazoxid (til behandling af højt blodtryk eller lavt blodsukker) - rifampicin (til behandling af infektioner, tuberkulose) - glukagon (til behandling af lavt blodsukker i alvorlig grad) 
coughs and colds or used in life-threatening emergencies) - nicotinic acid (to treat high cholesterol level) - long-term use of laxatives (to treat constipation) - phenytoin (to treat fits) - barbiturates (to treat nervousness and sleep problems) - azetazolamide (to treat increased pressure in the eye also called glaucoma) - diazoxide (to treat high blood pressure or low blood sugar) - rifampicin (to treat infections, tuberculosis) - glucagon (to treat severe low blood sugar levels)
LÆGEMIDLETS NAVN Tandemact 45 mg/4 mg tabletter pioglitazon/glimepirid 
NAME OF THE MEDICINAL PRODUCT Tandemact 45 mg/4 mg tablets pioglitazone/glimepiride
Almindelige: (kan påvirke op til 1 ud af 10 behandlede) - vægtstigning - svimmelhed - luft i maven - luftvejsinfektion - følelsesløshed 
- weight gain - dizziness - gas - respiratory infection - numbness
Hver Tandemact 30 mg/2 mg tablet indeholder 30 mg pioglitazon (som hydrochlorid) og 2 mg glimepirid. 
Each Tandemact 30 mg/2 mg tablet contains 30 mg pioglitazone (as hydrochloride) and 2 mg glimepiride.
Tandemact indeholder lactosemonohydrat Kontakt lægen, før De tager Tandemact, hvis lægen har fortalt Dem, at De ikke tåler visse sukkerarter. 
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Tandemact.
LÆGEMIDLETS NAVN Tandemact 30 mg/2 mg tabletter pioglitazon/glimepirid 
NAME OF THE MEDICINAL PRODUCT Tandemact 30 mg/2 mg tablets pioglitazone/glimepiride
Da glimepirid kan medføre hypoglykæmi eller hyperglykæmi, kan patientens evne til at koncentrere sig og reagere være nedsat. 
The patient's ability to concentrate and react may be impaired as a result of hypoglycaemia or hyperglycaemia from glimepiride or, for example, as a result of visual impairment.
EU/1/06/366/005 14 tabletter EU/1/06/366/006 28 tabletter EU/1/06/366/007 30 tabletter EU/1/06/366/008 50 tabletter EU/1/06/366/009 90 tabletter EU/1/06/366/010 98 tabletter 
EU/1/06/366/005 14 tablets EU/1/06/366/006 28 tablets EU/1/06/366/007 30 tablets EU/1/06/366/008 50 tablets EU/1/06/366/009 90 tablets EU/1/06/366/010 98 tablets
Hjælpestof, som behandleren skal være opmærksom på Hver tablet indeholder cirka 177 mg lactosemonohydrat (se pkt. 
Each tablet contains approximately 177 mg lactose monohydrate (see section 4.4).